Introduction
============

Heterochromatin is a conserved feature of eukaryotic chromosomes and plays an important role in chromosome segregation, genomic stability and gene regulation. In the fisson yeast *Schizosaccharomyces pombe*, heterochromatin is formed at centromeres, telomeres and the mating-type (*mat*) locus ([@b38]). Centromeres are composed of a central domain (*cnt*), which has a specialised chromatin structure associated with the histone H3 variant Cnp1/CENP-A, flanked by heterochromatic outer repeats (*otr*) ([@b27]). At centromeres, tRNA genes ([@b33]) and the IRCs ([@b5]) have been implicated in confining heterochromatin. At the mating-type locus, the *mat2* and *mat3* silent donor loci and the K region are packaged into heterochromatin constrained by the IR-R and IR-L barrier elements which recruit TFIIIC ([@b22], [@b23]; [@b35]).

In regions of silent chromatin, histones are generally underacetylated ([@b8]; [@b17]) and are methylated at lysine 9 of histone H3 (H3K9me) by the histone methyltransferase (HMTase) Clr4, a member of the highly conserved Suv39 family ([@b30]). The H3K9 methylation is a binding site for the chromodomain proteins: Swi6, Chp1 and Chp2 ([@b6]; [@b4]; [@b20]; [@b31]).

Transcription of the outer repeats by RNA polymerase II (RNAPII) generates noncoding RNA transcripts that are processed into small interfering RNAs (siRNAs) by the RNaseIII-like ribonuclease Dicer (Dcr1). siRNAs associate with the RNA-induced Initiation of Transcriptional Silencing (RITS) complex, which consists of Chp1, Argonaute (Ago1) and Tas3. The RITS complex uses the siRNAs to target it to homologous chromatin for silencing ([@b19]; [@b24]; [@b39]). Mutants in RNAi pathway proteins such as *dcr1*Δ*, ago1*Δ and *rpb2*, the second largest subunit of RNA polymerase II, lose centromeric silencing (reviewed by [@b38]). However, RNAi is dispensable for the maintenance of heterochromatin at the *mat* locus ([@b12]; [@b15]).

Previously, we proposed that *S. pombe* protein Epe1 and other members of the JmjC domain family are 2-OG/Fe(II)-dependent dioxygenases that may act as histone demethylases ([@b36]). Recently, several JmjC domain proteins have been demonstrated to have this activity (reviewed by [@b16]). Epe1 is distributed across all the major heterochromatic domains and certain meiotic genes ([@b41]). The observation that Epe1 blocks heterochromatin from forming beyond the IR-L barrier at the *mat* locus lead to the proposal that Epe1 is a negative regulator of heterochromatin ([@b3]). Loss of Epe1 leads to the downregulation of genes that are known to be upregulated in cells with defective silent chromatin, suggesting that Epe1 counteracts silencing of repressed genes ([@b11]). It has also been suggested that Epe1 directly facilitates the access of RNAPII to centromeric repeats and that Epe1 has a role at heterochromatin boundaries by facilitating transcription of the IRC boundary elements ([@b41]).

Here we show that contrary to previous reports, predicted Fe(II)- and 2-OG-binding residues are required for Epe1 function, suggesting that Epe1 is a 2-OG/Fe(II)-dependent dioxygenase. We also demonstrate that Epe1 acts at the chromatin level to prevent heterochromatin domains from both expanding and contracting.

Results
=======

Epe1 restrains heterochromatin to its normal domain
---------------------------------------------------

We initially identified Epe1 as an Swi6 interacting protein in a yeast two-hybrid screen. The Epe1 cDNA obtained corresponded to the region spanning from amino acid 652 to the C-terminus, indicating that the region containing the JmjC domain of Epe1 is not required for the interaction with Swi6 ([Supplementary Figure 1A](#S1){ref-type="supplementary-material"}). Consistent with this and the observations of others ([@b41]; [@b11]), GFP-tagged Epe1 was found to colocalise with Swi6 at heterochromatin. This localisation is dependent on Swi6, Clr4 and Rik1 ([Supplementary Figure 1B](#S1){ref-type="supplementary-material"}).

As Epe1 is localised to heterochromatin, we investigated its role in heterochromatin stability using marker genes inserted within and outside centromeric heterochromatin at centromere 1 (*cen1*). Genes placed within the centromeres are transcriptionally silenced due to the formation of H3K9 methylation/Swi6-dependent heterochromatin ([@b2]; [@b9]). In the case of the *ura4*^+^ marker gene, this silencing results in restricted growth on selective plates that lack uracil (−URA) and good growth on counter-selective plates that contain 5-fluoroorotic acid (FOA). Genes inserted in the distal extremity of *cen1* are less silent (sites 3 and 4: [Figure 1A](#f1){ref-type="fig"}; [@b2]) and genes inserted in the euchromatin immediately adjacent to *cen1* are expressed well (sites 1 and 2: [Figure 1A](#f1){ref-type="fig"}). Deletion of the gene encoding Epe1 (*epe1*Δ) results in enhanced silencing of markers inserted at the extremities of the *cen1* outer repeat (sites 3 and 4), indicated by increased growth on FOA. In addition, loss of Epe1 causes significant silencing of the normally fully expressed marker genes in adjacent euchromatin (sites 1 and 2; [Figure 1B](#f1){ref-type="fig"}). Chromatin immunoprecipitation (ChIP) analysis was performed to examine the level of H3K9me2, a well-characterised histone modification associated with silent chromatin. In *epe1*Δ cells, high levels of H3K9me2 are found at the normally euchromatic region outside of the centromere ([Figure 1C](#f1){ref-type="fig"}). This agrees with previous observations showing that in *epe1*Δ cells, silent chromatin extends into nearby euchromatic regions and results in gene silencing ([@b3]; [@b41]).

Epe1 is required for centromeric heterochromatin integrity
----------------------------------------------------------

Loss of Epe1 promotes spreading of silent chromatin from heterochromatin domains into euchromatin ([Figure 1](#f1){ref-type="fig"}; [@b3]; [@b41]). However, the effect of *epe1*Δ on heterochromatin integrity has not been tested. To address this, we examined the effect of the *epe1*Δ mutation on silencing of an *ade6*^+^ gene inserted within the centromeric outer repeats ([Figure 2A](#f2){ref-type="fig"}). In wild-type cells, this *ade6*^+^ gene (*cen1-otr1R(Sph*I*):ade6*^+^) is strongly repressed, resulting in the formation of red colonies on plates with limiting adenine, due to the accumulation of a red adenine precursor. Conversely, *clr4*Δ cells that lack the histone H3K9 methyltransferase are unable to assemble heterochromatin, resulting in full expression of the *ade6*^+^ marker and the formation of white colonies. Unusually, *epe1*Δ colonies exhibit variegation, resulting in white, pink and red colonies ([Figure 2B](#f2){ref-type="fig"}). The state of silencing of *cen1-otr1:ade6*^+^ switches frequently in an *epe1*Δ population, so that when white colonies are replated they often give rise to red and pink colonies and *vice versa* ([Supplementary Figure 2](#S1){ref-type="supplementary-material"}). Thus, although these *epe1*Δ isolates are genetically identical, they display distinct metastable silent and expressed states, which must reflect epigenetic differences in centromeric heterochromatin integrity.

We also tested whether loss of Epe1 affects silencing of a *ura4*^+^ gene located within centromeric heterochromatin (*cen1-imr1L(Nco*I*):ura4*^+^; [Figure 2A](#f2){ref-type="fig"}). In wild-type strains, this *ura4*^+^ gene is strongly silenced, allowing good growth on FOA and low levels of growth on media lacking uracil. In contrast, the silencing in *epe1*Δ cells variegates (data not shown). Colonies with the *ura4*^+^ gene in the transcriptionally silent or active states were picked from FOA or −URA plates and their ability to grow was assessed when challenged with selective (−URA) or counter selective (FOA) medium. *epe1*Δ colonies expressing the *ura4*^+^ gene (from −URA plates) were consistently able to sustain this active state, allowing better growth on −URA plates than similarly preselected wild-type colonies ([Figure 2C](#f2){ref-type="fig"}). In reciprocal experiments, FOA-resistant *epe1*Δ cells selected for silencing of *imr1L(Nco*I*):ura4*^+^ gene (from FOA plates) were less capable than wild type in sustaining this repressed state resulting in more growth on −URA ([Figure 2C](#f2){ref-type="fig"}). Together, this indicates that silent chromatin at centromeres is less stable in the absence of Epe1.

We show that loss of Epe1 causes not only spreading of heterochromatin into euchromatic regions, but also the destabilisation of heterochromatin within the centromere. The destabilisation of silencing observed in the absence of Epe1 is inconsistent with the previously proposed role for Epe1 as a factor that acts to prevent heterochromatin spreading past specific boundary elements ([@b3]; [@b41]).

Epe1 is required for normal centromere function
-----------------------------------------------

It is well established that mutants with defective centromeric heterochromatin, such as *swi6*Δ, *clr4*Δ and *rik1*Δ, have chromosome segregation defects; they display lagging chromosomes on late anaphase spindles and are sensitive to microtubule-destabilising drug thiabendazole (TBZ) ([@b6]; [@b7]). If loss of Epe1 leads to disruption of heterochromatin, then *epe1*Δ cells would be expected to display similar chromosome segregation defects. *epe1*Δ colonies in which *cen1-otr1(Sph*I*):ade6*^+^ was silent (red) or expressed (white) were replated in a serial dilution assay on plates containing 15 μg/ml TBZ. Cells derived from white *epe1*Δ colonies consistently displayed greater TBZ sensitivity than wild type; however, genetically identical red *epe1*Δ colonies were not very TBZ sensitive compared to wild type ([Figure 2D](#f2){ref-type="fig"}). This indicates that TBZ sensitivity covariegates with the silent/expressed state, implying that cells with less intact silent chromatin are more prone to chromosome mis-segregation events.

*epe1*Δ cells exhibit lagging chromosomes at an elevated frequency compared to wild-type cells. A higher incidence of lagging chromosomes was observed in cultures derived from white *otr1(Sph*I*):ade6*^+^ colonies than their genetically identical red/pink relatives ([Figure 2E](#f2){ref-type="fig"}). This indicates that the white-expressed state caused by loss of Epe1 is incompatible with normal chromosome segregation and is consistent with Epe1 being required for centromeric heterochromatin integrity and centromere function. Therefore, white *epe1*Δ colonies, in a manner similar to *swi6*Δ cells, exhibit defective centromeric heterochromatin, which results in loss of silencing, lagging chromosomes and TBZ sensitivity.

Loss of Epe1 causes heterochromatin to oscillate
------------------------------------------------

Epe1 is required to restrict domains of heterochromatin, and in its absence heterochromatin spreads into surrounding euchromatin ([Figure 1](#f1){ref-type="fig"}; [@b3]; [@b41]). However, contrary to this, our analysis demonstrates that Epe1 is required for normal heterochromatin integrity since loss of Epe1 destabilises silencing at centromeres and causes chromosome segregation defects. It is surprising that these seemingly opposing effects could be caused by absence of the same protein. A possible explanation for this phenotype is that expansion of a silent domain disrupts silencing at more internal sites, perhaps by titrating away essential components of heterochromatin. An alternative explanation is that in the absence of Epe1, the silent chromatin domains oscillate, either expanding into euchromatin or retreating to allow alleviation of silencing.

To address these possibilities, a strain was constructed with a *ura4*^+^ in a normally nonsilent euchromatic site (*otr1R*(*Xho*I):*ura4*^+^) and, on the same side of the centromere, an *ade6*^+^ gene within the silent *otr* region (*otr1R(Sph*I*):ade6*^+^; [Figure 3A](#f3){ref-type="fig"}). Wild-type cells silence the centromeric *ade6*^+^ gene, forming red colonies and express the euchromatic *ura4*^+^ gene. Some *epe1*Δ colonies form an extended heterochromatin domain, silencing the euchromatic *ura4*^+^ gene (FOA^R^ colonies). The majority of these *epe1*Δ colonies are red or pink ([Figure 3A](#f3){ref-type="fig"}), indicating that in the absence of Epe1 centromeric heterochromatin is not disrupted when silent chromatin extends into neighbouring euchromatin.

Also, when centromeric heterochromatin is disrupted in *epe1*Δ cells, silencing does not spread into the euchromatin. This is demonstrated by white (*cen1-otr1*:*ade6*^+^ expressing) *epe1*Δ cells which when replated showed good expression of the euchromatic *ura4*^+^ gene (poor growth on FOA). However, occasionally, white *epe1*Δ colonies with disrupted centromeric silencing gave rise to a few colonies on FOA plates, however, these were red/pink rather than white. This again indicates that in *epe1*Δ cells, repression of *ura4*^+^ outside the normal silent domain requires silencing to be intact in the adjacent outer repeats ([Figure 3A](#f3){ref-type="fig"}).

A similar experiment was performed with a strain in which the *ura4*^+^ gene was inserted at the equivalent position in the euchromatin on the opposite side of the centromere to the *ade6*^+^ marker ([Figure 3B](#f3){ref-type="fig"}). Again, when *epe1*Δ cells were plated on FOA to select colonies in which heterochromatin has spread over the *ura4*^+^ gene, the colonies formed were red or pink, indicating that *ade6*^+^ is repressed on the other side of the centromere ([Figure 3B](#f3){ref-type="fig"}). Therefore, silencing must be maintained across the outer repeats on the left-hand side of the centromere to allow the expansion of the heterochromatin domain on the right-hand side.

Together, these data indicate that in *epe1*Δ cells the spreading of heterochromatin beyond the normal centromeric domain does not destabilise silent chromatin within the centromere. It also indicates that *epe1*Δ mutants require intact heterochromatin on both left and right centromeric *otr* repeats in order to form an extended heterochromatin domain. Therefore, loss of Epe1 leads to a more erratic form of silent chromatin, allowing heterochromatin to oscillate, retreating or extending over greater distances than observed in the wild-type cells.

Heterochromatin expansion occurs independently of boundaries in epe1*Δ* cells
-----------------------------------------------------------------------------

Epe1 has been proposed to act at boundaries because peaks of Epe1 localisation have been found to coincide with, and promote the transcription of IRC elements ([@b41]). Moreover, IRC elements have been demonstrated to act as boundary elements ([@b23]). However, if Epe1 functions only at boundary elements, loss of Epe1 would be expected to have no effect on an ectopically silenced locus where no known boundary elements are present. The ectopic silencer strain contains a 1.6 kb fragment from the outer repeat of centromere 3 (L5) inserted at the *ade6* locus ([Figure 4A](#f4){ref-type="fig"}) and has been shown to efficiently silence an adjacent *ura4*^+^ marker gene but not the *ade6*^+^ gene 1.3 kb downstream of the *ura4*^+^ ORF. H3K9me2, Swi6 and Chp1 are associated with this ectopically silenced *ura4*^+^ and this silencing is dependent on RNAi and heterochromatin components. Thus, the silent chromatin formed at this ectopic site (*ade6*:L5-*ura4*^+^) is indistinguishable from that found at the centromeric repeats themselves ([@b25]; [@b40]). In wild-type strains, silencing of this *ade6:L5-ura4*^+^ reporter allows good growth on FOA relative to −URA plates ([Figure 4A](#f4){ref-type="fig"}). However, some *epe1*Δ cells display increased growth on −URA relative to wild type ([Figure 4A](#f4){ref-type="fig"}). This suggests that loss of Epe1 destabilises heterochromatin at the ectopic silencer. ChIP analysis shows that in *epe1*Δ cells with disrupted silencing, H3K9me2 decreases and H3K9 acetylation increases on the *ura4*^+^ marker ([Supplementary Figure 4](#S1){ref-type="supplementary-material"}).

Conversely, we examined whether deletion of *epe1* allows spreading of heterochromatin at this ectopic site to silence the *ade6*^+^ gene that resides 1.3 kb downstream of *ura4*^+^ ([Figure 4A](#f4){ref-type="fig"}). In wild-type cells, this *ade6*^+^ gene remains expressed, resulting in white colonies. In contrast, *epe1*Δ cells containing the same *ade6:L5-ura4*^+^ form a significant number of red and pink colonies on nonselective plates. The frequency of these red/pink (*ade6* repressed) colonies increases when cells with a silent *ura4*^+^ gene are selected on FOA plates ([Figure 4B](#f4){ref-type="fig"}). Thus, in the absence of Epe1, silent chromatin can extend further from the L5/centromeric repeat fragment and silence both *ura4*^+^ and *ade6*^+^ genes. When *epe1*Δ mutants are grown on −URA media to select for cells that are expressing the *ura4*^+^ gene, the frequency of colonies in which heterochromatin has spread from the L5 to silence the downstream *ade6*^+^ is very low. This suggests that in *epe1*Δ mutants, heterochromatin spreads in a contiguous and directional fashion and is consistent with previous data ([@b3]).

This analysis indicates that at an ectopic silencer, where there is no boundary between adjacent *ura4*^+^ and *ade6*^+^ genes, Epe1 is required both for robust silencing and to counteract heterochromatin spreading. As at *cen1*, in the absence of Epe1, silencing variegates and heterochromatin domains fluctuate. Therefore, although Epe1 may indeed have a role at boundaries, Epe1 does not act solely at boundaries. Epe1 clearly acts both to prevent spreading at sites that lack known boundary elements and to prevent disruption of heterochromatin, suggesting that Epe1 has a direct role in regulating the extent and integrity of heterochromatin domains.

Epe1 does not act via the RNAi pathway
--------------------------------------

It has been proposed that Epe1 acts in the RNAi pathway to recruit RNAPII to centromeric repeats, and thereby promoting the production of noncoding transcripts ([@b41]). An alternative possibility is that Epe1 acts independently of RNAi and functions at the chromatin level, for example by directly modifying a heterochromatin factor. To determine if Epe1 resides in the RNAi pathway, we examined hallmark criteria that distinguish between RNAi factors and heterochromatin factors. RNAi components are required both for the establishment and maintenance of silencing at centromeres. Thus, reintroduction of the histone H3 lysine 9 methyltransferase Clr4 into *chp1*Δ*clr4*Δ cells does not allow the reestablishment of silent chromatin ([@b31]). However, when Clr4 is reintroduced into a *clr4*Δ*epe1*Δ double mutant, heterochromatin is formed ([Supplementary Figure 3](#S1){ref-type="supplementary-material"}). Thus, functional Epe1 is not an absolute requirement for the establishment of the silent state at centromeres.

The RNAi machinery has been shown to be dispensable for maintenance of silencing at the mating-type locus ([@b12]; [@b15]). Silencing at the mating-type locus was examined using a *ura4*^+^ marker gene inserted 150 bp distal to *mat3* (*mat3-M(Eco*RV):*ura4*^+^; [Figure 4C](#f4){ref-type="fig"}). In wild-type cells and *dcr1*Δ mutants, the marker at this site is strongly silenced, resulting in poor growth on −URA plates. However, we find that in some *epe1*Δ and *epe1*Δ*dcr1*Δ colonies, silencing is alleviated giving better growth than wild type on −URA plates ([Figure 4C](#f4){ref-type="fig"}). This indicates that loss of Epe1 causes variable silencing at the *mat* locus with some colonies exhibiting disrupted silencing. *epe1*Δ cells have also been shown to form extended domains of heterochromatin at the *mat* locus ([@b3]). Therefore, it is possible that at the *mat* locus, silencing oscillates in a similar fashion to that observed at centromeres. Defective silencing of *mat3(Eco*RV*):ura4*^+^ in *epe1*Δ cells is consistent with Epe1 not acting in the RNAi pathway, this suggests that Epe1 acts to regulate silent chromatin and/or is a component of silent chromatin itself.

Loss of Epe1 allows heterochromatin to expand without active RNAi
-----------------------------------------------------------------

To determine if in the absence of the RNAi pathway, loss of Epe1 can still result in the formation of extended heterochromatin domains, we examined silencing in *dcr1*Δ mutants and cells bearing a mutation in Rpb2. *rpb2-m203* mutants lack centromeric siRNA and loses centromeric silencing due to the inability of the mutant RNAPII to recruit RNAi components ([@b14]). We examined *rpb2-m203* and *dcr1*Δ strains with *ura4*^+^ markers inserted in the centromeric heterochromatin of *cen1* (*otr1R(Sph*I*):ura4*^+^ and *imr1L(Nco*I*):ura4*^+^ respectively). Silencing in the *epe1*Δ*rpb2-m203* double mutant variegates, so colonies were preselected on −URA and FOA. Analysis demonstrates that an *epe1*Δ mutant can suppress the silencing defect of an *rpb2-m203* mutant ([Figure 5A](#f5){ref-type="fig"}). Stronger silencing (FOA^R^) is observed in the *epe1*Δ*rpb2-m203* double mutant compared to the *rpb2-m203* mutant alone. Mutations in *epe1* are also able to suppress the loss of centromeric silencing observed in the RNAi-deficient *dcr1*Δ mutant, the enzyme responsible for siRNA generation ([Figure 5B](#f5){ref-type="fig"}). Therefore, in the absence of Epe1, heterochromatin spreads along the centromeric repeats even without intact RNAi. Previous analyses have demonstrated that a moderate level of H3K9me2 methylation persists in an RNAi-deficient background ([@b31]). The most plausible explanation for our observations is that in the absence of Epe1, silent chromatin can extend outwards using this residual H3K9 methylation as a nucleation point for the expansion of silent chromatin along the chromatin fibre without RNAi components or siRNAs.

We next examined centromeric heterochromatin formed in *epe1*Δ*, dcr1*Δ and an *epe1*Δ*dcr1*Δ double mutant. ChIP analysis demonstrates that in *dcr1*Δ cells, the level of H3K9me2 is reduced below wild-type levels. Compared to *dcr1*Δ, H3K9me2 is significantly increased in the *epe1*Δ*dcr1*Δ double mutant ([Figure 5C](#f5){ref-type="fig"}). This indicates that *epe1*Δ cells can maintain H3K9 methylation in the absence of RNAi.

Furthermore, to confirm that in the absence of the RNAi pathway *epe1*Δ mutants can form extended heterochromatin domains, silent chromatin was examined at a synthetic telomere. At this synthetic telomere, heterochromatin is established independently of the RNAi pathway as it is composed of terminal TTACAG~1−6~ repeats but lacks the proximal telomere-associated repeats through which RNAi mediates silencing ([@b13]). The synthetic telomere was created adjacent to the *ade6*^+^ gene on the minichromosome Ch16. In wild-type cells, the *ade6*^+^ gene juxtaposed to the synthetic telomere exhibits variegated expression resulting in red, pink, white and sectored colonies ([@b21]). To assess silencing of the *ade6*^+^ gene, red (repressed) colonies were replated. The red *epe1*Δ colonies maintain the red silent state more effectively than red wild-type cells ([Figure 5D](#f5){ref-type="fig"}). This suggests that loss of Epe1 allows more robust heterochromatin to form at the synthetic telomere, consistent with an extended silent domain. Again, no known boundary exists between telomere repeats and the *ade6*^+^ gene.

Together, these data indicate that in the absence of Epe1, heterochromatin can expand ([Figure 5](#f5){ref-type="fig"}) and be disrupted ([Figure 4C](#f4){ref-type="fig"}) in the absence of functional RNAi.

epe1*Δ* cells display low levels of siRNAs derived from centromeric transcripts
-------------------------------------------------------------------------------

Noncoding RNAPII transcripts derived from the centromeric outer repeats are processed by the RNAi pathway to produce siRNAs. To determine if Epe1 affects or is required for the production of these noncoding centromeric RNAs, transcript levels were assessed by Northern blot and RT--PCR. As expected, the level of centromeric transcript in the wild type is low, but transcripts accumulate in *dcr1*Δ cells. We observe that in *epe1*Δ*dcr1*Δ double mutants, the levels of transcript observed are significantly reduced compared to that of the *dcr1*Δ background ([Figure 6A](#f6){ref-type="fig"}). This is consistent with previous observations ([@b41]). However, in *epe1*Δ*dcr1*Δ cells (and also in *epe1*Δ), the levels of centromeric transcript detected are inversely correlated with the level of phenotypic silencing. Strains containing a *ura4*^+^ marker within the centromeric heterochromatin (*cen1-imr1L(Nco*I*):ura4*^+^) were grown in media containing FOA to select for the repressed state and media lacking uracil to enrich for cells in which heterochromatin is disrupted. In *epe1*Δ*dcr1*Δ cells, more transcripts accumulate when silencing is disrupted than when silencing is intact ([Figure 6B](#f6){ref-type="fig"}). This suggests that in *epe1*Δ cells, the stochastic loss and formation of heterochromatin over the centromeric repeats (and the transcript promoters) regulates the amount of centromeric transcription. Therefore, the overall reduction in centromeric transcript detected in *epe1*Δ*dcr1*Δ cells is caused by loss of regulation of heterochromatin. This suggests that the effect Epe1 has on centromeric transcription is indirect and provides an alternative explanation for the reduced levels of RNAPII associated with the heterochromatic repeats and IRC elements observed in *epe1*Δ cells ([@b41]).

Consistent with a misregulation of heterochromatin in *epe1* mutants causing reduced centromere repeat transcription, Northern analyses of siRNAs homologous to centromeric *dh* repeats revealed that siRNAs levels are variable but lower in *epe1*Δ cells compared to the wild type ([Figure 6C](#f6){ref-type="fig"}). siRNA levels do not cause the variegation in silencing as siRNA levels are not higher in cells with extended heterochromatin domains, than in cells with disrupted heterochromatin ([Supplementary Figure 5](#S1){ref-type="supplementary-material"}). Also, the low level of siRNAs is not the cause of the disruption of silencing, because *epe1*Δ cells have defective silencing at the *mat* locus where siRNAs are not required to maintain silencing ([Figure 4C](#f4){ref-type="fig"}). Therefore, since we have demonstrated that in *epe1*Δ cells the expansion and disruption of heterochromatin is independent of the RNAi pathway, the erratic behaviour of heterochromatin observed must be due to defective regulation of heterochromatin rather than reduced siRNA levels.

Epe1 requires iron- and 2-OG-binding residues for activity
----------------------------------------------------------

Previously, we demonstrated that the JmjC domain of Epe1 can be modelled on the structure of FIH (Factor inhibiting HIFα) ([@b36]). FIH is a member of the 2-OG/Fe(II)-dependent dioxygenase superfamily, which bind Fe(II) using the consensus amino-acid residues HXD/EX~*n*~H ([@b32]). Epe1 contains a variant of this motif in which the second histidine is replaced with tyrosine (HXEX~70~Y), therefore, we predicted that Epe1 coordinates Fe(II) with the residues H297, E299 and Y370. The structural model also suggested that Epe1 would interact with its co-substrate 2-OG via K314 along with two additional amino acids ([@b36]).

More recently it has been suggested that Epe1 is not an active dioxygenase enzyme. This was proposed due to the lack of *in vitro* histone demethylase activity (data not shown; [@b37]; [@b41]) and Epe1 overexpression studies. Overexpression of either wild-type protein or Epe1 mutated in a predicted Fe(II)-binding residue causes the disruption of centromeric heterochromatin ([@b41]). This suggested that the critical H297 residue, predicted to bind Fe(II), is dispensable for Epe1 function. However, this interpretation neglects the possibility that the defective silencing observed is due to Epe1 overexpression rather than Epe1 activity.

To investigate further, wild-type Epe1 and the mutant proteins Epe1-H297A and Epe1-K314A ([Figure 7A](#f7){ref-type="fig"}), with defective Fe(II)-binding and 2-OG-interacting residues, respectively, were overexpressed from the *nmt41* promoter on a high copy plasmid. The Epe1-H297A and Epe1-K314A proteins are stable and expressed at a similar level to the wild-type Epe1 protein ([Figure 7E](#f7){ref-type="fig"}). Overexpression of the wild-type Epe1, Epe1-H297A or Epe1-K314A in a strain containing the normally strongly repressed *cen1-otr1R(Sph*I*):ade6*^+^ marker, alleviated silencing, so that mainly white colonies were formed compared with the red colonies formed with the empty plasmid control ([Figure 7C](#f7){ref-type="fig"}). Similarly, in a strain bearing *otr1R(Sph*I*):ura4*^+^, overexpression of wild-type or the Epe1 point mutants resulted in the majority of colonies exhibiting increased growth on −URA plates, consistent with defective centromeric heterochromatin formation ([Figure 7D](#f7){ref-type="fig"}). Therefore, the H297 and K314 residues are not required for the disruption of silencing observed when Epe1 is overexpressed.

However, to determine if these critical residues are really required for Epe1 function, the same H297A and K314A alterations were made in the open reading frame of endogenous *epe1*^+^ gene expressed from its native promoter. Interestingly, the *epe1-H297A* and *epe1-K314A* mutants have phenotypes that are indistinguishable from *epe1*Δ. Like *epe1*Δ cells, both *epe1-H297A* and *epe1-K314A* cells exhibit variegated expression of *cen1-otr1R(Sph*I*):ade6*^+^, resulting in red, pink and white colonies ([Figure 7F](#f7){ref-type="fig"}). Moreover, *epe1-H297A* and *epe1-K314A* cells have extended centromeric chromatin domains, H3K9me2 can spread from the centromere ([Supplementary Figure 6](#S1){ref-type="supplementary-material"}) resulting in silencing of a *ura4*^+^ marker gene located in a normally expressed euchromatic site as indicated by increased growth on FOA ([Figure 7G](#f7){ref-type="fig"}). These analyses clearly demonstrate that the *in vivo* activity of the Epe1 protein is abolished by the H297A and K314A mutations. This indicates that the predicted Fe(II)-binding and 2-OG-interacting residues are essential for Epe1 function. Furthermore, this is consistent with Epe1 being an active enzyme of the 2-OG/Fe(II)-dependent dioxygenase superfamily. The disruption of silencing observed when Epe1 is overexpressed is therefore not due to the enzymatic activity of Epe1. These analyses contradict previous reports that suggested that these residues are not important for Epe1 function and that Epe1 is not a 2-OG/Fe(II)-dependent dioxygenase.

Discussion
==========

Here we have demonstrated that Epe1 regulates the stability of heterochromatin domains. Our analyses have show that loss of Epe1 causes silencing to variegate with some *epe1*Δ cells forming extended silent chromatin domains ([Figures 1](#f1){ref-type="fig"} and [3](#f3){ref-type="fig"}) while other genetically identical *epe1*Δ cells have destabilised heterochromatin ([Figures 2](#f2){ref-type="fig"}, [3](#f3){ref-type="fig"} and [4](#f4){ref-type="fig"}). These silent and expressed states are metastable ([Supplementary Figure 2](#S1){ref-type="supplementary-material"}). We propose that in *epe1*Δ cells, silent chromatin domains oscillate, expanding into the surrounding euchromatin or contracting to cause alleviation of silencing ([Figure 3](#f3){ref-type="fig"}).

We suggest that Epe1 acts directly to prevent the oscillation of heterochromatin domains rather than via boundary elements. Although Epe1 may have a specific role at heterochromatin boundaries, our data plainly demonstrates that Epe1 stabilises heterochromatin in the absence of known boundary elements ([Figures 4](#f4){ref-type="fig"} and [5D](#f5){ref-type="fig"}).

Epe1 could either act in the RNAi pathway or at the chromatin level to regulate the stability of heterochromatin domains. Our analyses show that Epe1 is not a component of the RNAi pathway and therefore must function at the chromatin level. Unlike RNAi factors, Epe1 is not required for the establishment of centromeric heterochromatin ([Supplementary Figure 3](#S1){ref-type="supplementary-material"}). Also, loss of Epe1 causes variegated silencing at the *mat* locus ([Figure 4C](#f4){ref-type="fig"}), where RNAi is dispensable for maintenance of heterochromatin ([@b10]). In fact, in *epe1*Δ cells, heterochromatin can spread independently of RNAi ([Figure 5](#f5){ref-type="fig"}). We postulate that residual pockets of H3K9me2 that remain in RNAi mutants ([@b31]) may act as nucleation sites from which, in the absence of Epe1, heterochromatin can spread. Therefore, the erratic behaviour of heterochromatin observed is due to aberrant regulation of heterochromatin rather than by an RNAi defect. Our data suggest that Epe1 does not regulate RNAPII ([@b41]), but that Epe1 regulates the integrity of heterochromatin and therefore indirectly effects access of RNAPII to centromeric chromatin.

Heterochromatin may spread along fibres in a transcription/RNAi-coupled manner. Or, in an alternative model, spreading might be caused by the polymerisation of chromatin factors in a step-wise fashion, for example, a nucleation site of Swi6, bound to H3K9me2, could recruit a histone deacetylase and Clr4, allowing H3K9 methylation of adjacent nucleosomes and binding of additional Swi6 (reviewed by [@b34]). Our results demonstrate that in the absence of Epe1, heterochromatin can spread or collapse without active RNAi, therefore, suggesting that Epe1 may prevent heterochromatin from spreading and collapsing via the step-wise assembly mechanism. We propose that Epe1 dampens the natural tendency of silent chromatin to assemble or disassemble. Thus, in the absence of Epe1, minor fluctuations in the extent of silent chromatin domains remain unchecked and the process is unregulated, resulting in frequent expansion--contraction of the silent domain ([Figure 8](#f8){ref-type="fig"}).

Epe1 is likely to be an active 2-OG/Fe(II)-dependent dioxygenase. Contrary to other reports, we have demonstrated that a predicted iron-binding residue (H297) and 2-OG-binding residue (K314) are essential for the *in vivo* activity of Epe1 ([Figure 7](#f7){ref-type="fig"}). However, no histone demethylase activity can be detected *in vitro* for Epe1 (unpublished observation; [@b37]; [@b41]). Although Epe1 could be a histone demethylase, the lack of *in vitro* activity leads us to propose an alternative mechanism for Epe1. It is possible that Epe1 acts analogously to another JmjC domain protein, FIH, to which Epe1 has strong structural homology ([@b36]). FIH is a protein hydroxylase that hydroxylates Asn803 of HIF and prevents it binding to the histone acetylase p300 ([@b32]). We propose that Epe1 could be a protein hydroxylase that affects the stability of a heterochromatin protein, or protein--protein interaction, to regulate the extent and stability of heterochromatin domains. Hydroxylation of a heterochromatin factor could regulate the stability of silent chromatin, effectively buffering the extent of heterochromatin formed adjacent to a nucleation site. There are many potential substrates for Epe1. As Epe1 interacts with Swi6 ([Supplementary Figure 1](#S1){ref-type="supplementary-material"}; [@b41]; [@b11]), it is possible that Epe1 hydroxylates Swi6. However, it is equally possible that Epe1 prevents silent chromatin from oscillating by hydroxylating other components of silent chromatin. For example, Epe1 could directly regulate the activity or stability of the Clr4 methyltransferase, histone deacetylases or another heterochromatin protein.

Materials and methods
=====================

Fission yeast strains and genetic methods
-----------------------------------------

The media and standard genetic procedures used were described previously ([@b18]; [@b1]). Epe1 was deleted by homologous integration of *ura4*^+^ to replace the ORF. The *epe1*∷KanMX4 mutant was derived from a diploid strain obtained from Bioneer (Korea). The *otr1R(Sph*I*):ade6*^+^ *otr1R*(*Xho*I):*ura4*^+^ strain was constructed by transformation of the *Bam*HI fragment of the p*Phe*-otr1(*Xho*I)-ura4 plasmid ([@b2]) into cells containing *otr1R(Sph*I*):ade6*^+^. The successful integration of *ura4*^+^ at the *Xho*I site was determined by PCR and Southern blot.

Serial dilution assays
----------------------

Strains or single colonies were spotted in either a 10- or five-fold dilution onto the appropriate plates and incubated for 4 days at 32°C. To assess the sensitivity to TBZ, serial dilutions were spotted onto YES+15 μg/ml TBZ. For the analysis at the mating-type locus, h^90^ colonies were identified for analysis by their brown colour when stained with iodine.

Immunostaining and lagging chromosome analysis
----------------------------------------------

Cells were fixed and stained as previously described ([@b7]). For lagging chromosome analysis, 100 late anaphases (spindle \>5 μm) for each strain were analysed. Details of microscopy were described previously ([@b29], [@b28]).

Western blot
------------

Whole-cell extracts were prepared from logarithmically growing cells. Cells were harvested, resuspended in trichloroacetic acid and vortexed with beads. The acid-soluble proteins were boiled in SDS--PAGE loading buffer and used for immunoblotting. Blots were probed with an anti-Epe1 antibody and anti-BIP antibody as a loading control.

ChIP
----

ChIP was performed as described ([@b26]) except for the following modifications. For H3K9me2 ChIP, cells were fixed with 1% PFA for 15 min at room temperature. Cells were lysed using a bead beater (Biospec products) and sonicated using a Bioruptor (Diagenode) sonicator for a total of 15 min (30 s ON and OFF cycle). Monoclonal H3K9me2 antibody (1 μl) was used per ChIP. Multiplex PCR products were separated on 1.7% agarose gels and post-stained with ethidium bromide. Quantitation of bands was performed using the Kodak EDAS 290 system and 1D Image Analysis Software (Eastman Kodak).

siRNA and centromeric transcript preparation
--------------------------------------------

For RT--PCR, cells were resuspended in 10 mM Tris--HCl, pH 7.5, 10 mM EDTA, pH 8, 0.5% SDS and lysed with the addition of phenol:chloroform 5:1, acid washed beads and vortexed for 30 min at 65°C. The aqueous phase was chloroform extracted and the RNA ethanol precipitated. The RT--PCR was performed using SuperScript III Reverse Transcriptase (Invitrogen). For northern blots, RNA was extracted by resuspending cells in 50 mM Tris--HCl pH 7.5, 10 mM EDTA pH 8, 100 mM NaCl, 1% SDS, lysing by the addition of phenol:chloroform 5:1, acid washed beads and vortexing for 30 min at 4°C. The soluble fraction was extracted with phenol/chloroform and ethanol precipitated. Centromeric transcripts were precipitated with 10% polyethylene glycol 8000 and 0.5 M NaCl on ice for 30 min followed by centrifugation. siRNAs were precipitated by addition of ethanol and sodium acetate and incubation at −20°C for 3 h. Transcripts were run on a 1% agarose 6% formaldehyde gel. siRNA samples were run on an 8% polyacrylamide gel. To check for loading, siRNA gels were cut above the xylene cyanol band and stained with ethidium bromide. siRNA and transcript gels were blotted by capillary transfer onto Hybond-NX (Amersham) and UV crosslinked. Transcript gels were probed with a ^32^P-labelled PCR product homologous to the *dg* centromeric repeats. siRNA gels were probed with a PCR product homologous to the *dh* repeats, and as a loading control an oligonucleotide homologous to a snoRNA.

Construction of plasmid mutants
-------------------------------

Epe1 was cloned into the pDONR201 entry plasmid (Invitrogen). Point mutations were introduced into the Epe1 entry plasmid using the QuikChange Site-Directed Mutagenesis Kit (Stratagene). The wild-type and mutated Epe1 ORFs were LR recombined into a *S. pombe* expression plasmid under control of the *nmt41* promoter. The wild-type and point mutated Epe1 ORFs were checked by sequencing.

Construction of genomic mutants
-------------------------------

A PCR product containing the *epe1H297A* point mutation was obtained by amplification of the mutated *epe1* gateway entry plasmid. Primers were used with 80 base pair of homology to the region surrounding Epe1. The *epe1K314A* mutant DNA fragment was obtained using a two-step PCR protocol, creating a product with 200 base pair of homology either side of the ORF. PCR products were transformed into *epe1∷ura4*^+^ or *epe1∷KanMX4* strains. Colonies were screened for replacement of the marker and point mutants were checked by sequencing.
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![Epe1 restrains heterochromatin to its normal domain. (**A**) Location of *ura4*^+^ markers at the extremities of *cen1*. Outside of *cen1* markers were inserted at the *Hpa*I (site 1) and *Xho*I (site 2) sites. At the extremities of the *otr*, markers were inserted in opposite orientations at the *Bgl*II site (sites 3 and 4). (**B**) *epe1*Δ causes expansion of centromeric heterochromatin. *epe1*Δ cells with the *ura4*^+^ marker inserted at the indicated site were spotted onto the indicated media. (**C**) H3K9me2 ChIP analysis of wild-type (WT) and *epe1*Δ strains containing the indicated *ura4*^+^ insertion compared with the *uraDS/E* mini-gene.](7601892f1){#f1}

![Epe1 is required for normal centromeric heterochromatin integrity. (**A**) A *ura4*^+^ marker was inserted at the *Nco*I site of the *imr* and an *ade6*^+^ marker was inserted in the *Sph*I site in the *otr*. (**B**) Loss of Epe1 causes variegation of silencing at the centromere *otr*. Single colonies of *epe1*Δ with *ade6*^+^ at the *Sph*I site in the *otr* were spotted onto media containing a low level of adenine. (**C**) Loss of Epe1 causes loss of silencing at the centromere *imr.* Cells containing *ura4*^+^ marker inserted in the *Nco*I site of the *imr* were preselected on either media lacking uracil or containing FOA. Colonies were then spotted onto the indicated plates. (**D**) Loss of Epe1 causes chromosome segregation defects. Single colonies of *epe1*Δ mutants with *ade6*^+^ at the *otr* were spotted onto media containing low levels of adenine and media containing 15 μg/ml TBZ. (**E**) *epe1*Δ cells exhibit lagging chromosomes (indicated by arrow). The number of anaphase cells with lagging chromosomes was assessed in white and red/pink *otr1:ade6*^+^ *epe1*Δ cells as well as wild-type (WT) and *swi6*Δ.](7601892f2){#f2}

![Loss of Epe1 causes heterochromatin to oscillate. Strains were constructed with an *ade6*^+^ marker inserted at the *Sph*I site on the right *otr* of *cen1* and a *ura4*^+^ marker at the *Xho*I site on the same side of the centromere (**A**) or on the opposite side of the centromere (**B**). Single colonies were picked from wild-type (WT) and *epe1*Δ strains and spotted onto the indicated plates. Single red or white colonies were replated onto the indicated media, 500 of the resulting colonies were classified according to their colour. The numbers indicated are representative of several experiments.](7601892f3){#f3}

![Heterochromatin oscillates independently of boundaries and the RNAi pathway. (**A**) Loss of Epe1 causes disruption of silencing at the ade6:L5-*ura4* ectopic silencer; a fragment of the *otr* of *cen3* (L5) is inserted at the euchromatic *ade6*^+^ locus adjacent to a *ura4*^+^ gene. Unselected colonies were plated onto indicated media. (**B**) Loss of Epe1 allows spreading of heterochromatin in the absence of boundary elements. White colonies containing the ade6:L5-*ura4* ectopic silencer were replated and the colour of the resulting colonies was assessed. The numbers indicated are representative of several experiments. (**C**) Loss of Epe1 alleviates silencing of a *ura4*^+^ marker genes inserted 150 bp distal to *mat3* (*mat3-M*(*Eco*RV):*ura4*^+^). Unselected single colonies were plated onto indicated media.](7601892f4){#f4}

![Loss of Epe1 allows heterochromatin to expand without active RNAi. *epe1*Δ can partially rescue the phenotypes of *rpb2-m203* (**A**) and *dcr1*Δ (**B**) mutants, which have defective RNAi. (**C**) ChIP analysis of levels of H3K9me2 on the centromeric outer repeats (*dg* region) was compared to that of the euchromatic *fbp1*^+^ gene. (**D**) *epe1*Δ causes expansion of telomeric heterochromatin. Strains were used which contain a minichromosome that has an *ade6*^+^ gene next to a telomere. Red wild-type (WT) and *epe1*Δ colonies were picked and spotted or plated onto media containing limited adenine, the colour of the resulting colonies was assessed. The numbers presented are representative of several experiments.](7601892f5){#f5}

![*epe1*Δ mutants display low levels of siRNAs derived from centromeric transcripts. (**A**) Centromeric transcripts levels are reduced in an *epe1*Δ*dcr1*Δ compared with a *dcr1*Δ mutant. The transcripts were detected using a centromere-specific probe. As a loading control, levels of larger ribosomal RNAs were visualised by EtBr staining. (**B**) RT--PCR to analyse levels of centromeric transcript in cells containing a *ura4*^+^ marker in the centromere (*cen1-imr1L(Nco*I*):ura4*^+^) grown in the absence of uracil and in media containing FOA. (**C**) Levels of siRNAs are reduced in an *epe1*Δ mutant. siRNAs were detected using a probe specific for the *dh* repeats. As a loading control, the blot was also hybridised with a probe specific for a snoRNA.](7601892f6){#f6}

![Epe1 requires iron- and 2-OG-binding residues for activity. (**A**) Multiple alignments of JmjC domain proteins. The *Saccharomyces cerevisiae* (sc) JHD1, *Homo sapiens* (hs) JHDM1A and *S. pombe* (sp) Epe1 proteins are shown. Predicted Fe(II)-binding residues are highlighted in red and the predicted 2-OG-binding residues are highlighted in green. The conserved Fe(II)- and 2-OG-binding residues, H297 and K314, of Epe1 are indicated by ♦. (**B**) Strains containing the *ura4*^+^ or *ade6*^+^ marker inserted at the *Sph*I site of the *otr.* (C, D) Plasmids containing Epe1 or Epe1 point mutants were overexpressed from an *nmt41* promoter in strains with *ade6*^+^ (**C**) or *ura4*^+^ (**D**) at the *Sph*I site of *otr1.* Overexpression of Epe1 and *epe1*H297A and K314A point mutants cause disruption of centromeric silencing. (**E**) Western blot of extracts from cells overexpressing Epe1 or Epe1 point mutants from an *nmt41* promoter in a wild-type background. (**F**) Genomic *epe1H297A* and *K314A* mutants exhibit variegation of centromeric silencing. *epe1H297A* and *K314A* point mutants with *otr1R(Sph*I*):ade6*^+^ were spotted onto media containing low adenine. (**G**) Genomic *epe1H297A* and *K314A* mutants of Epe1 cause spreading of centromeric heterochromatin. *epe1H297A* and *K314A* point mutants with *ura4*^+^ at the *Xho*I site adjacent to *cen1* were spotted onto the indicated media.](7601892f7){#f7}

![Model for the function of Epe1. Epe1 prevents the oscillation of silent chromatin. In *dcr1*Δ cells, residual pockets of H3K9me2 may act as nucleation sites from which, in the absence of Epe1, heterochromatin can spread.](7601892f8){#f8}
